Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Dr. Christine Chen Dr. Christine Chen is an Associate Professor at the University of Toronto (U of T) and Medical Director of the Autologous Stem Cell Transplant Program at the Princess Margaret Cancer Centre, University Health Network (UHN), in Toronto, Canada. Dr. Chen is a member of the clinical research group for multiple myeloma and related mature B-cell disorders, including chronic lymphocytic leukemia (CLL) and Waldenstrom’s macroglobulinemia (WM). Princess Margaret Cancer Centre is the largest tertiary care center for cancer in Canada, performing over 200 autologous stem cell transplants per year and seeing over 400 new referrals for myeloma, CLL and WM. Dr. Chen is a clinical investigator with research interests focusing on the development of novel approaches for these disorders. Dr. Chen underwent her internal medicine training at the University of British Columbia in Vancouver and hematology residency training at McMaster University in Hamilton. Upon completing a transplant clinical research fellowship at Princess Margaret Cancer Centre, she joined the faculty of the Department of Medical Oncology and Hematology at the U of T and subsequently obtained her Masters in Education from the Ontario Institute of Studies in Education (U of T). She therefore also takes an active role in medical education and acted as the U of T Hematology Training Program Director from 20032008 and is the current education coordinator for the myeloma group.